Lemaitre Vascular (LMAT) Gross Margin (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Gross Margin data on file, last reported at 72.72% in Q1 2026.

• Gross Margin for Q1 2026 came in at 72.72%, up 354.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 72.39% (up 359.0% YoY), and the FY2025 annual result was 71.53%, up 290.0% from the prior year.
• Gross Margin grew to 72.72% in Q1 2026 per LMAT's latest filing, from 71.66% in the prior quarter.
• Over five years, Gross Margin peaked at 75.28% in Q3 2025 and troughed at 63.62% in Q4 2022.
• A 5-year average of 67.98% and a median of 68.05% in 2023 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2022 and 2025: Gross Margin plunged 209 bps in 2022, then soared 746 bps in 2025.
• A 5-year view of Gross Margin shows it stood at 63.62% in 2022, then advanced by 7 bps to 68.05% in 2023, then rose by 2 bps to 69.26% in 2024, then grew by 3 bps to 71.66% in 2025, then advanced by 1 bps to 72.72% in 2026.
• Business Quant data shows LMAT's Gross Margin at 72.72% in Q1 2026, 71.66% in Q4 2025, and 75.28% in Q3 2025.